Nanobody‐Engineered Natural Killer Cell Conjugates for Solid Tumor Adoptive Immunotherapy
Abstract
Cancer immunotherapy based on natural killer (NK) cells is demonstrated to be a promising strategy. However, NK cells are deficient in ligands that target specific tumors, resulting in limited antitumor efficacy. Here, a glycoengineering approach to imitate the chimeric antigen receptor strategy and decorate NK cells with nanobodies to promote NK‐based immunotherapy in solid tumors is proposed. Nanobody 7D12, which specifically recognizes the human epidermal growth factor receptor (EGFR) that is overexpressed on many solid tumors, is coupled to the chemically synthesized DBCO‐PEG4‐GGG‐NH2 by sortase A‐mediated ligation to generate DBCO‐7D12. The NK92MI cells bearing azide groups are then equipped with DBCO‐7D12 via bioorthogonal click chemistry. The resultant 7D12‐NK92MI cells exhibit high specificity and affinity for EGFR‐overexpressing tumor cells in vitro and in vivo by the 7D12‐EGFR interaction, causing increased cytokine secretion to more effectively kill EGFR‐positive tumor cells, but not EGFR‐negative cancer cells. Importantly, the 7D12‐NK92MI cells also show a wide anticancer spectrum and extensive tumor penetration. Furthermore, mouse experiments reveal that 7D12‐NK92MI treatment achieves excellent therapeutic efficacy and outstanding safety. The authors’ works provide a cell modification strategy using specific protein ligands without genetic manipulation and present a potential novel method for cancer‐targeted immunotherapy by NK cells.Keywords
Funding Information
- National Natural Science Foundation of China (81972220, 32000904)
- Natural Science Foundation of Jiangsu Province (BK20200601)
- China Postdoctoral Science Foundation (BX20200153)
This publication has 56 references indexed in Scilit:
- Nanobodies: Natural Single-Domain AntibodiesAnnual Review of Biochemistry, 2013
- Sortase-Mediated Transpeptidation for Site-Specific Modification of Peptides, Glycopeptides, and ProteinsJournal of Carbohydrate Chemistry, 2012
- Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of CancerJournal of Immunotherapy, 2011
- Strategies and challenges for the next generation of therapeutic antibodiesNature Reviews Immunology, 2010
- Natural killer cell‐based immunotherapy in cancer: current insights and future prospectsJournal of Internal Medicine, 2009
- Sortase‐Mediated Ligation: A Gift from Gram‐Positive Bacteria to Protein EngineeringChemBioChem, 2009
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008
- Drug penetration in solid tumoursNature Reviews Cancer, 2006
- Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cellsBlood, 2005
- Cell Surface Engineering by a Modified Staudinger ReactionScience, 2000